
|Articles|July 1, 2004
Frozen version of cellular matrix speeds healing of venous leg ulcers
Miami - Pivotal trial results show that treatment with a cryopreserved, bilayered cellular matrix (OrCel, Ortec International) promotes healing of refractory venous leg ulcers, especially those of dermal depth, says Robert S. Kirsner, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Phase 2 Nemolizumab Trial Opens for CPUO
5


















